Efficacy and tolerability of bimatoprost versus travoprost in patients previously on latanoprost: a 3-month, randomised, masked-evaluator, multicentre study.

Kammer, J A; Katzman, B; Ackerman, S L; Hollander, D A

Kammer, J A; Katzman, B; Ackerman, S L; Hollander, D A.

Affiliation

Kammer JA; Vanderbilt Eye Institute, 2311 Pierce Ave, Nashville, TN 37232-8808, USA. jeffrey.kammer@vanderbilt.edu

Br J Ophthalmol ; 94(1): 74-9, 2010 Jan.

Article in En | MEDLINE | ID: mdl-19726422

Subject(s)

Amides/therapeutic use; Antihypertensive Agents/therapeutic use; Cloprostenol/analogs & derivatives; Ocular Hypertension/drug therapy; Adolescent; Adult; Aged; Aged, 80 and over; Amides/adverse effects; Antihypertensive Agents/adverse effects; Bimatoprost; Cloprostenol/adverse effects; Cloprostenol/therapeutic use; Female; Glaucoma, Open-Angle/drug therapy; Glaucoma, Open-Angle/physiopathology; Humans; Intraocular Pressure/drug effects; Latanoprost; Male; Middle Aged; Ocular Hypertension/physiopathology; Prospective Studies; Prostaglandins F, Synthetic/therapeutic use; Single-Blind Method; Travoprost; Treatment Outcome; Young Adult

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ocular Hypertension / Cloprostenol / Amides / Antihypertensive Agents Type of study: Clinical_trials / Observational_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Br J Ophthalmol Year: 2010 Document type: Article

Fulltext

XML

PubMed Links

Search on Google